This therapeutic effect is recently further demonstrated in colorectal cancer, where glycyrrhizin was shown to significantly downregulate the NHEJ pathway through direct inhibition of HMGB1, resulting in reduced cell viability and increased DNA damage [38]. This evidence concerns the gene HMGB1 and colorectal cancer.